NISA INVESTMENT ADVISORS, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,701
+1.2%
5,325
+0.6%
0.00%
Q2 2023$37,249
+232706.2%
5,291
+175.6%
0.00%
Q1 2023$16
-78.1%
1,920
-69.8%
0.00%
-100.0%
Q4 2022$73
-99.9%
6,350
+0.2%
0.00%0.0%
Q3 2022$85,000
+28.8%
6,339
+2.1%
0.00%0.0%
Q2 2022$66,000
-34.7%
6,2100.0%0.00%0.0%
Q1 2022$101,000
-5.6%
6,210
-10.5%
0.00%0.0%
Q4 2021$107,000
-35.2%
6,940
-39.7%
0.00%0.0%
Q3 2021$165,000
-9.3%
11,5000.0%0.00%0.0%
Q2 2021$182,000
+50.4%
11,500
-3.6%
0.00%0.0%
Q1 2021$121,000
+450.0%
11,925
+307.7%
0.00%
Q4 2020$22,000
+214.3%
2,925
+41.0%
0.00%
Q3 2020$7,000
-30.0%
2,0750.0%0.00%
Q2 2020$10,000
+150.0%
2,075
+5.3%
0.00%
Q1 2020$4,000
-50.0%
1,970
+97.0%
0.00%
Q1 2017$8,000
+14.3%
1,000
-61.5%
0.00%
Q1 2016$7,0002,6000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders